American Portfolios Advisors Athenex, Inc. Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Mar 21, 2023
BUY
$0.79 - $1.59 $904 - $1,820
1,145 New
1,145 $950,000
Q4 2021

Mar 21, 2023
BUY
$1.36 - $2.94 $1,557 - $3,366
1,145 New
1,145 $1.56 Million
Q3 2021

Mar 22, 2023
BUY
$2.97 - $4.84 $3,400 - $5,541
1,145 New
1,145 $3.45 Million
Q2 2021

Mar 22, 2023
BUY
$3.71 - $5.13 $4,247 - $5,873
1,145 New
1,145 $5.29 Million
Q1 2021

Mar 22, 2023
BUY
$4.08 - $14.75 $4,671 - $16,888
1,145 New
1,145 $4.92 Million
Q4 2020

Mar 22, 2023
BUY
$11.06 - $14.01 $5,530 - $7,005
500 New
500 $5.53 Million

Others Institutions Holding ATNX

# of Institutions
3
Shares Held
1.46M
Call Options Held
0
Put Options Held
0
View Full List

About Athenex, Inc.

ATNX Quotes by TradingView
  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email